166 related articles for article (PubMed ID: 31170898)
1. Is There a Role for Desensitization in Intestinal Transplantation?
Santeusanio AD; Moon J; Nair V; Iyer KR
Prog Transplant; 2019 Sep; 29(3):275-278. PubMed ID: 31170898
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the Immunological Barrier in Highly HLA Sensitized Renal Transplant Recipients - A Desensitization Experience from a Transplant Center in Pakistan.
Mirza S; Mahmud SN; Abideen ZU; Aziz T; Akhter S; Baloch BK
J Pak Med Assoc; 2019 Apr; 69(4):584-587. PubMed ID: 31000868
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of bortezomib desensitization among heart transplant candidates.
Brinkley DM; Mangione M; Fossey SC; Harrison KM; Zalawadiya S; Rali AS; Siddiqi HK; Lindenfeld J; Schlendorf KH
Clin Transplant; 2023 Apr; 37(4):e14907. PubMed ID: 36661196
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous Immunoglobulin.
Revollo JY; Cuffy MC; Abu Jawdeh BG; Paterno F; Girnita A; Brailey P; Alloway RR; Woodle ES
Transplant Proc; 2015 Sep; 47(7):2254-7. PubMed ID: 26361693
[TBL] [Abstract][Full Text] [Related]
6. Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation.
Jeong JC; Jambaldorj E; Kwon HY; Kim MG; Im HJ; Jeon HJ; In JW; Han M; Koo TY; Chung J; Song EY; Ahn C; Yang J
Medicine (Baltimore); 2016 Feb; 95(5):e2635. PubMed ID: 26844479
[TBL] [Abstract][Full Text] [Related]
7. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
8. Desensitization in kidney transplantation: review and future perspectives.
Abu Jawdeh BG; Cuffy MC; Alloway RR; Shields AR; Woodle ES
Clin Transplant; 2014 Apr; 28(4):494-507. PubMed ID: 24621089
[TBL] [Abstract][Full Text] [Related]
9. Progress in Desensitization of the Highly HLA Sensitized Patient.
Jordan SC; Choi J; Kahwaji J; Vo A
Transplant Proc; 2016 Apr; 48(3):802-5. PubMed ID: 27234740
[TBL] [Abstract][Full Text] [Related]
10. HLA desensitization with bortezomib in a highly sensitized pediatric patient.
May LJ; Yeh J; Maeda K; Tyan DB; Chen S; Kaufman BD; Bernstein D; Rosenthal DN; Hollander SA
Pediatr Transplant; 2014 Dec; 18(8):E280-2. PubMed ID: 25174602
[TBL] [Abstract][Full Text] [Related]
11. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
[TBL] [Abstract][Full Text] [Related]
12. Management of sensitized pediatric patients prior to renal transplantation.
Pirojsakul K; Desai D; Lacelle C; Seikaly MG
Pediatr Nephrol; 2016 Oct; 31(10):1691-8. PubMed ID: 26801944
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of Highly Immunized Kidney Transplant Recipients Awaiting Transplantation-Polish Single-Center Experience.
Kuźmiuk-Glembin I; Komorowska-Jagielska K; Moszkowska G; Chamienia A; Dębska-Ślizień A
Transplant Proc; 2024 May; 56(4):796-801. PubMed ID: 38688729
[TBL] [Abstract][Full Text] [Related]
14. Highly Sensitized Patients: Miami Transplant Institute Experience.
Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
[TBL] [Abstract][Full Text] [Related]
15. Limitations of rituximab/IVIg desensitization protocol in kidney transplantation; is this better than a tincture of time?
Kozlowski T; Andreoni K
Ann Transplant; 2011; 16(2):19-25. PubMed ID: 21716181
[TBL] [Abstract][Full Text] [Related]
16. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
[TBL] [Abstract][Full Text] [Related]
17. Rituximab and intravenous immune globulin for desensitization during renal transplantation.
Vo AA; Lukovsky M; Toyoda M; Wang J; Reinsmoen NL; Lai CH; Peng A; Villicana R; Jordan SC
N Engl J Med; 2008 Jul; 359(3):242-51. PubMed ID: 18635429
[TBL] [Abstract][Full Text] [Related]
18. Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab.
Kahwaji J; Jordan SC; Najjar R; Wongsaroj P; Choi J; Peng A; Villicana R; Vo A
Transpl Int; 2016 Dec; 29(12):1276-1285. PubMed ID: 27529314
[TBL] [Abstract][Full Text] [Related]
19. Antibody desensitization therapy in highly sensitized lung transplant candidates.
Snyder LD; Gray AL; Reynolds JM; Arepally GM; Bedoya A; Hartwig MG; Davis RD; Lopes KE; Wegner WE; Chen DF; Palmer SM
Am J Transplant; 2014 Apr; 14(4):849-56. PubMed ID: 24666831
[TBL] [Abstract][Full Text] [Related]
20. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
